SynthesisCancer2026
Control arm overperformance in phase 3 oncology clinical trials.
Ansel P Nalin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this paperpooled itcites it
SynthesisCancer2026
Ansel P Nalin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.